Sarepta Therapeutics (SRPT) Jumped On Better Than Expected Q2 Results

Sarepta Therapeutics (SRPT) reported a second quarter non-GAAP loss of $0.46 per share after the bell Wednesday, compared to the loss of 1.19 per share last year. Analysts expected a loss of $0.91 per share.

from RTT - Before the Bell http://ift.tt/2gPwXAM
via IFTTT